BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8557515)

  • 1. Detectability of early brain meningitis with magnetic resonance imaging.
    Runge VM; Wells JW; Williams NM; Lee C; Timoney JF; Young AB
    Invest Radiol; 1995 Aug; 30(8):484-95. PubMed ID: 8557515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detectability of small liver metastases with gadolinium BOPTA.
    Runge VM; Lee C; Williams NM
    Invest Radiol; 1997 Sep; 32(9):557-65. PubMed ID: 9291044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic abscesses. Magnetic resonance imaging findings using gadolinium-BOPTA.
    Runge VM; Wells JW; Williams NM
    Invest Radiol; 1996 Dec; 31(12):781-8. PubMed ID: 8970881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetization transfer and high-dose contrast in early brain infection on magnetic resonance.
    Runge VM; Wells JW; Kirsch JE
    Invest Radiol; 1995 Mar; 30(3):135-43. PubMed ID: 7797410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-enhanced magnetic resonance imaging in a spinal epidural tumor model.
    Runge VM; Lee C; Iten AL; Williams NM
    Invest Radiol; 1997 Oct; 32(10):589-95. PubMed ID: 9342117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of standard and high-dose contrast-enhanced breath-hold liver magnetic resonance for visualization of metastatic disease in an animal model.
    Runge VM
    Invest Radiol; 1998 May; 33(5):263-7. PubMed ID: 9609484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of gadolinium 2,5-BPA-DO3A, a new macrocyclic hepatobiliary chelate, in normal liver and metastatic disease on high field magnetic resonance imaging.
    Runge VM; Wells JW; Williams NM
    Invest Radiol; 1996 Jan; 31(1):11-6. PubMed ID: 8850360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of gadolinium Cy2DOTA, a new hepatobiliary agent, and gadolinium HP-DO3A, an extracellular agent, in healthy liver and metastatic disease.
    Runge VM; Wells JW; Williams NM
    Invest Radiol; 1995 Feb; 30(2):123-30. PubMed ID: 7782188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early dynamic magnetic resonance imaging of liver metastases with 0.3 and 0.6 mmol/kg gadoteridol injection.
    Runge VM; Wells JW; Williams NM
    Invest Radiol; 1996 Aug; 31(8):472-8. PubMed ID: 8854193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging of an experimental model of intracranial metastatic disease. A study of lesion detectability.
    Runge VM; Wells JW; Williams NM
    Invest Radiol; 1994 Dec; 29(12):1050-6. PubMed ID: 7721546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal metastasis. Detection and characterization on enhanced magnetic resonance imaging using an animal model.
    Runge VM; Wells JW; Williams NM
    Invest Radiol; 1997 Apr; 32(4):212-7. PubMed ID: 9101356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging in a spinal abscess model. Preliminary report.
    Runge VM; Williams NM; Lee C; Timoney JF
    Invest Radiol; 1998 Apr; 33(4):246-55. PubMed ID: 9556750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visualization of blood-brain barrier disruption on MR images of cats with acute cerebral infarction: value of administering a high dose of contrast material.
    Runge VM; Kirsch JE; Wells JW; Dunworth JN; Woolfolk CE
    AJR Am J Roentgenol; 1994 Feb; 162(2):431-5. PubMed ID: 8310940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Brain magnetic resonance with magnetization transfer in multiple sclerosis. Lesion hyperintensity before and after intravenous gadolinium administration].
    Renzetti P; Parodi RC; Losacco C; Rosso E; Arcuri T; Sardanelli F
    Radiol Med; 1999 Sep; 98(3):138-43. PubMed ID: 10575442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gadoteridol in multiple sclerosis patients. A comparison of single and triple dose with immediate vs. delayed imaging.
    Wolansky LJ; Finden SG; Chang R; Conigliari M; Lee HJ; Shaderowsky PD; Cook SD
    Clin Imaging; 1998; 22(6):385-92. PubMed ID: 9876905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of cerebral perfusion by first-pass, dynamic, contrast-enhanced, steady-state free-precession MR imaging: an animal study.
    Runge VM; Kirsch JE; Wells JW; Woolfolk CE
    AJR Am J Roentgenol; 1993 Mar; 160(3):593-600. PubMed ID: 8430562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging of experimental pyelonephritis in rabbits.
    Runge VM; Timoney JF; Williams NM
    Invest Radiol; 1997 Nov; 32(11):696-704. PubMed ID: 9387058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of gadolinium-BOPTA on magnetic resonance imaging in brain infection.
    Runge VM; Wells JW; Williams NM; Timoney JF; Lee C
    Invest Radiol; 1996 May; 31(5):294-9. PubMed ID: 8724129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detectability of metastatic brain tumors using gadoteridol-enhanced MRI: usefulness of standard-dose T1-weighted spin-echo image with magnetization transfer and enhanced FLAIR].
    Annoura K; Utsunomiya H; Arai S; Okazaki M
    Nihon Igaku Hoshasen Gakkai Zasshi; 2000 Mar; 60(3):77-82. PubMed ID: 10741113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose applications of gadolinium chelates in magnetic resonance imaging.
    Runge VM; Kirsch JE; Thomas GS
    Magn Reson Med; 1991 Dec; 22(2):358-63. PubMed ID: 1812371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.